Tillman Gerngross is the CEO and co-founder of Adimab, and a professor of engineering at Dartmouth. His conversation with Nature Biotechnology covers his years at GlycoFi, the nature of problem solving in entrepreneurship, and Adimab’s paper last year challenging the work of MIT researcher Ram Sasisekharan.